EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Impact of school‐supervised ultra‐long‐acting basal insulin injections on ketosis in youth with T1D and elevated haemoglobin A1c: A pilot study

Laura M Nally iD, Jennifer L Sherr iD, Eileen Tichy, Kate Weyman, Andrea Urban, Veronika Shabanova, Sarah McCollum, Amy Steffen, William V Tamborlane, Michelle Van Name iD

Diabetic Medicine · 2023

DOI: 10.1111/dme.15123 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diabetic Medicine, 2023. Verfasst von Laura M Nally und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, COVID-19, Diabetic Ketoacidosis, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, Novo Nordisk.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In youth with type 1 diabetes (T1D), high haemoglobin A1c (HbA1c) levels are associated with an increased risk for diabetic ketoacidosis (DKA).

Aims

This study examined whether daily school‐supervised basal insulin injections were feasible and if they reduced the risk of morning ketosis in children and adolescents with high HbA1c levels. We hypothesized that supervised glargine and degludec would reduce the risk of ketosis and that the prolonged action of degludec would protect from ketosis after consecutive days of unsupervised injections. Materials & Methods After a 2–4‐week run‐in, youth (10–18 years, HbA1c ≥ 8.5%) managing T1D with injections were randomized to school‐supervised administration of degludec or glargine for 4 months. School nurses observed daily blood β‐hydroxybutyrate (BHB) and glucose checks. During COVID closures, the research team supervised procedures remotely.

Results

Data from 28 youth (age 14.3 ± 2.3 years, HbA1c 11.4 ± 1.9%, 64% F) were analysed. School‐supervised injections of both basal insulins for 1–4 days progressively lowered the percent of participants with elevated BHB. The percent of participants with elevated BHB (≥0.6 mmol/L) after 2 days of unsupervised basal insulin doses at home was greater in the glargine than degludec group but had a high p ‐value (17.2% vs. 9.0%, p = 0.3). HbA1c was unchanged in both groups.

Discussion

In youth with T1D at high risk for DKA, daily supervised long‐acting insulin administration decreased the probability of elevated ketone levels on subsequent school days, regardless of basal insulin type. A larger sample size may have demonstrated that the longer action profile of degludec would offer additional protection from ketosis during days of not attending school.

Conclusion

Engaging school‐based caregivers in management of youth with T1D on injected insulin may decrease clinically significant ketosis and minimize acute complications of diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1COVID-19Diabetic KetoacidosisNeoplasmsChildHumansAdolescentInsulin GlargineGlycated HemoglobinHypoglycemic AgentsPilot ProjectsInsulinBlood Glucose

Stichwörter der Autor:innen

degludecdiabetic ketoacidosisglargineschooltype 1 diabetes

Substanzen

Insulin GlargineGlycated HemoglobinHypoglycemic AgentsInsulinBlood Glucose

Autor:innen und Institutionen

  • Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Department of Biostatistics, Yale University School of Medicine, New Haven, Connecticut, USA.

ORCID-Profile: Laura M Nally, Jennifer L Sherr, Michelle Van Name

Förderung

  • NIDDK NIH HHS
  • Novo Nordisk

Zitieren

APA

Nally, L. M., Sherr, J. L., Tichy, E., Weyman, K., Urban, A., Shabanova, V., McCollum, S., Steffen, A., Tamborlane, W. V., & Van Name, M. (2023). Impact of school‐supervised ultra‐long‐acting basal insulin injections on ketosis in youth with T1D and elevated haemoglobin A1c: A pilot study. Diabetic Medicine. https://doi.org/10.1111/dme.15123

Vancouver

Nally LM, Sherr JL, Tichy E, Weyman K, Urban A, Shabanova V, et al. Impact of school‐supervised ultra‐long‐acting basal insulin injections on ketosis in youth with T1D and elevated haemoglobin A1c: A pilot study. Diabetic Medicine. 2023. doi:10.1111/dme.15123

BibTeX
@article{Nally2023,
  author = {Nally, Laura M and Sherr, Jennifer L and Tichy, Eileen and Weyman, Kate and Urban, Andrea and Shabanova, Veronika and McCollum, Sarah and Steffen, Amy and Tamborlane, William V and Van Name, Michelle},
  title = {Impact of school‐supervised ultra‐long‐acting basal insulin injections on ketosis in youth with T1D and elevated haemoglobin A1c: A pilot study},
  journal = {Diabetic Medicine},
  year = {2023},
  doi = {10.1111/dme.15123}
}
Kostenlos starten →